Phenotypic Diversity and Clinico-Hematological Profile of Hb E-Beta Thalassemic Children

Aditi Baruah1, Mrinal Kumar Baruah2

  • 11Department of Pediatrics, Assam Medical College, Dibrugarh, Assam India.

Insights

This study analyzed the clinical and hematological diversity in children with Hemoglobin E-Beta thalassemia. Severity depends on multiple factors, not just one parameter, highlighting the disease

Area of Science:

  • Hematology
  • Pediatrics
  • Genetics

Background:

  • Hemoglobin E-Beta thalassemia presents with significant clinical variability.
  • Understanding this phenotypic diversity is crucial for effective patient management.

Purpose of the Study:

  • To analyze the phenotypic diversity of Hemoglobin E-Beta thalassemia in children.
  • To identify clinical and hematological parameters influencing disease severity.

Main Methods:

  • Cross-sectional study involving 62 children (1 month to 18 years) with Hb E-β thalassemia.
  • Data collected via history, physical examination, and laboratory investigations.
  • Analysis of clinical findings, Hb levels, HbF levels, and anthropometric measurements.

Main Results:

  • High prevalence of severe disease (54.8%), stunting (64.5%), splenomegaly (93.5%), and facial deformities (87%).
  • Low initial Hb levels (<5 gm/dl) and high HbF levels (mean 32.6%) were observed.
  • No significant correlation between HbF levels and disease severity (p=0.0509).

Conclusions:

  • Disease severity in Hb E-β thalassemia is multifactorial, influenced by age at diagnosis, transfusion history, and organomegaly.
  • Comprehensive assessment using multiple clinical and hematological parameters is necessary for evaluating disease severity.
  • Further research into specific genetic and environmental factors may elucidate the observed clinical diversity.

Related Concept Videos

Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
37.7K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.6K
Blood Typing01:10

Blood Typing

Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
2.2K
Pedigree Analysis01:35

Pedigree Analysis

Overview
88.6K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
8.0K